Effect of isotretinoin on prothrombin time (PT), international normalized ratio (INR), and activated partial thromboplastin time (aPTT)
Increased incidence of venous thrombosis in patients with shortened activated partial thromboplastin times and low ratios for activated protein C resistance
Effects of sample storage time and temperature on prothrombin time (PT), activated partial thromboplastin time (APTT) and fibrinogen
Antifactor Xa Levels versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin
Assessment of Prothrombin Time, Activated Partial Thromboplastin Time, and Fibrinogen Concentration on Equine Plasma Samples following Different Storage Conditions
Detection of Mild Clotting Factor Deficiencies. Critical Role of the Activated Partial Thromboplastin Time (aPTT) Reagent
Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions
[Determination of heparin in pharmaceutical preparations by means of APTT (Activated Partial Thromboplastin Time)].
Detection of shortened activated partial thromboplastin times: An evaluation of different commercial reagents
Intraoperative measurement of activated partial thromboplastin time (APTT) and prothrombin time (IPT) with a new compact monitor